0000899243-19-017819.txt : 20190621
0000899243-19-017819.hdr.sgml : 20190621
20190621170837
ACCESSION NUMBER: 0000899243-19-017819
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190620
FILED AS OF DATE: 20190621
DATE AS OF CHANGE: 20190621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: King Sasha
CENTRAL INDEX KEY: 0001721150
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36536
FILM NUMBER: 19912319
MAIL ADDRESS:
STREET 1: C/O CAREDX, INC.
STREET 2: 3260 BAYSHORE BOULEVARD
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CareDx, Inc.
CENTRAL INDEX KEY: 0001217234
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 943316839
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3260 BAYSHORE BOULEVARD
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 415-287-2300
MAIL ADDRESS:
STREET 1: 3260 BAYSHORE BOULEVARD
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: XDx, Inc.
DATE OF NAME CHANGE: 20071010
FORMER COMPANY:
FORMER CONFORMED NAME: EXPRESSION DIAGNOSTICS INC
DATE OF NAME CHANGE: 20030203
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-20
0
0001217234
CareDx, Inc.
CDNA
0001721150
King Sasha
C/O CAREDX, INC.
3260 BAYSHORE BOULEVARD
BRISBANE
CA
94005
0
1
0
0
Chief Commercial Officer
Common Stock
2019-06-20
4
M
0
500
1.00
A
72772
D
Common Stock
2019-06-20
4
M
0
417
1.07
A
73189
D
Common Stock
2019-06-20
4
M
0
278
2.80
A
73467
D
Common Stock
2019-06-20
4
M
0
1667
5.90
A
75134
D
Common Stock
2019-06-20
4
M
0
833
6.31
A
75967
D
Common Stock
2019-06-20
4
M
0
12500
12.24
A
88467
D
Common Stock
2019-06-20
4
S
0
30840
38.3759
D
57627
D
Employee Stock Option (right to buy)
1.00
2019-06-20
4
M
0
500
0.00
D
2027-04-21
Common Stock
500
5500
D
Employee Stock Option (right to buy)
1.07
2019-06-20
4
M
0
417
0.00
D
2027-06-09
Common Stock
417
5000
D
Employee Stock Option (right to buy)
2.80
2019-06-20
4
M
0
278
0.00
D
2027-09-01
Common Stock
278
3750
D
Employee Stock Option (right to buy)
5.90
2019-06-20
4
M
0
1667
0.00
D
2027-10-27
Common Stock
1667
23333
D
Employee Stock Option (right to buy)
6.31
2019-06-20
4
M
0
833
0.00
D
2028-01-19
Common Stock
833
12917
D
Employee Stock Option (right to buy)
12.24
2019-06-20
4
M
0
12500
0.00
D
2028-06-29
Common Stock
12500
37500
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.59 to $40.32, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
25% of the shares subject to the option vested on March 30, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
25% of the shares subject to the option vested on June 9, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
50% of the shares subject to the option vested on September 1, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
1/4th of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
1/4th of the shares subject to the option shall vest on June 1, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter.
/s/ Peter Maag, as attorney-in-fact for Sasha King
2019-06-21